Please note that the contents in this webpage are current as of the date of the announcement and the information including but not limited to the product availability, specification, prices, contacts, are subject to change without prior notice.

• 2025.10.15

  • News Release

  PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

• 2025.10.01

  • Information

  Upcoming Conference Presentation at EANM’25（PeptiDream Inc）

• 2025.09.25

  • News Release

  Launch of “onti dandori” – A Scheduling Module for the “onti” System for Nuclear Medicine Exposure Dose Management

• 2025.09.19

  • News Release

  Bridgea DISPENSER Now Equipped with Liquid Collection Function — Enhancing Operational Efficiency and Safety in Radiopharmaceutical Preparation

• 2025.09.19

  • News Release

  PDRadiopharma Receives Approval for Expanded Indication of Raiatt MIBG-I131 for Neuroblastoma

• 2025.07.08

  • News Release

  PeptiDream Announces Submission of IND Application for Clinical Trials of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T

• 2025.06.25

  • News Release

  PDRadiopharma Inc. Announcement of the Releases of “AMYfollow TM”：Software for Supporting Longitudinal Reporting of Amyloid PET Imaging

• 2025.05.20

  • News Release

  PDRadiopharma Submits Partial Change Application for Additional Indication of Raiatt MIBG-I131 for Neuroblastoma

• 2025.04.07

  • Information
  • News Release

  Further Enhancements Added to the “onti” Medical Isotope Exposure Dose Management System

• 2025.03.31

  • Information

  PDRadiopharma Host Joint Seminar at The 84th Annual Meeting of the Japanese Society, and Exhibit at the International Technical Exhibition of Medical Imaging 2025